Release Date: 15/05/12 09:12 Summary: Update on acquisition approaches Price Sensitive: Yes Download Document 54.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%